Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center
Articles
Ongoing Issues in CAR T-Cell Therapy and Lymphoma
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
Allogenic CAR T-Cell Therapy in Lymphoma
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
CAR T-Cell Therapy’s Future for Lymphoma
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
CAR T Cells and Lymphoma Adverse Events
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
LBCL Therapy: The Right Therapy
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
R/R NHL: Candidate Identification and Referrals
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
CAR T-Cell Therapy for Follicular Lymphoma
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
ZUMA-2 Trial Overview: Mantle Cell Lymphoma Impact
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
LDH and ECOG Performance Tests
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
Liso-cel Therapy in R/R Large B-Cell Lymphoma
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
The Importance of Antigen Loss in R/R Disease
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
R/R Large B-Cell Therapy in Managing Various Lymphomas
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
CAR T-Cell Therapy in Managing Various Lymphomas
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
Rationale for Further Development of CAR T-Cell therapy
Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center
July 2nd 2020Read More
